154 PART THREE | DELIRIUM 51. Tan L, Liu J, Liu X et al. Clinical research of olanzapine for prevention of chemotherapy-induced nausea and vomiting. J Exp Clin Cancer Res 2009;28:131. 52. Zang J, Hou M, Gou HF et al. Antiemetic activity of megestrol acetate in patients receiving chemotherapy. Support Care Cancer 2011;19(5):667-73. 53. Ho CM, Ho ST, Wang JJ, et al. Dexamethasone has a central antiemetic mechanism in decerebrated cats. Anesth Analg 2004;99:734-9. 54. Mantovani G, Maccio A, Esu S, Lai P. Evidence that cisplatin induces serotonin release from human peripheral blood mononuclear cells and that methylprednisolone inhibits this effect. Eur J Cancer 1996;32A:1983-5. 55. Suzuki T, Sugimoto M, Koyama H, et al. Inhibitory effect of glucocorticoids on human-cloned 5-hydroxytryptamine 3A receptor expressed in xenopus oocytes. Anesthesiology 2004;101:660-5. 56. Tanihata S, Oda S, Nakai S, Uchiyama T. Antiemetic effect of dexamethasone on cisplatin-induced early and delayed emesis in the pigeon. Eur J Pharmacol 2004;484: 311-21. 57. Vardy J, Chiew KS, Galica J et al. Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. Br J Cancer 2006;94:10115. 58. Ng TL, Hutton B, Clemons M. Chemotherapy-induced nausea and vomiting: time for more emphasis on nausea? Oncologist 2015;20:576-83. 59. Aapro M. CINV: still troubling patients after all these years. Support Care Cancer 2018;26(Suppl 1):5-9. 60. Escobar Y, Cajaraville G, Virizuela JA et al. Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study. Support Care Cancer 2015;23:2833-40. 61. Roscoe JA, Heckler CE, Morrow GR et al. Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy. J Clin Oncol 2012;30:3389-95. 62. Martin AR, Pearson JD, Cai B et al. Assessing the impact of chemotherapyinduced nausea and vomiting on patients’ daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall. Support Care Cancer 2003;11:522-7. 63. Gaudreau JD, Gagnon P, Harel F et al. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 2005;23:6712-8. 64. Ljubisavljevic V, Kelly B. Risk factors for development of delirium among oncology patients. Gen Hosp Psychiatry 2003;25:345-52. 65. Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet 2014;383:911-22. 66. Oh ES, Fong TG, Hshieh TT, Inouye SK. Delirium in older persons: advances in diagnosis and treatment. JAMA 2017;318:1161-74. 67. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM5). Arlington: American Psychiatric Association 2013. 68. Stagno D, Gibson C, Breitbart W. The delirium subtypes: A review of prevalence, phenomenology, pathophysiology, and treatment response. Palliat Support Care 2004;2:171-9.
RkJQdWJsaXNoZXIy MjY0ODMw